ASEAN Heart Journal

First online: 

Case Reports

2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease

Victor L. Lazaro

23 March 2016

January 2016, 24:3

Case Reports

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

Reference Tools

References

1.Philippine Heart Association. 2009 PHA Clinical Practice Guidelines for the Management of Coronary Artery Disease. Quezon City: Philippine Heart Association, 2009.

 

2.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom- Lundqvist C, Borger MA, et al. Eur Heart J. 2012 Oct;33(20):2569–619.

 

3.O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29;127(4):e362–425.

PubMed

 

4.Yaneza LO, Abanilla JM, Abola MTB, Caole-Ang IV, Fernandez MBD, Lopez EA, Punzalan FER, Reyes EB; Steering Committee Members for the Philippine Heart Association-Acute Coronary Syndrome (PHA-ACS) Registry. Philippine Heart Association-Acute Coronary Syndrome Registry: 2 year Results. Phil J Cardiol 2013;2 (in press).

 

5.ISIS-2 (Second International Study of lnfarct Survival) Collaborative Group. Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17 187 Cases of Suspected Acute Myocardial Infarction: ISIS-2. Lancet 1988;332(8607):349–360.

CrossRef

 

6.Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al.; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005 Nov 5;366(9497):1607–21.

CrossRef   PubMed

 

7.Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, et al.; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fi brinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med.. 2005 Mar 24;352(12):1179–89.

 

8.Mehta SR, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J. 2000 Dec;21(24):2033–41.

CrossRef    PubMed

 

9.Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, et al.; TRITON-TIMI 38 Investigators. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006 Oct;152(4):627–35.

CrossRef    PubMed

 

10.Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al.; for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045–1057.

CrossRef    PubMed

 

11.Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare metal stents in patients with acute myocardial infarction. Eur Heart J 2007;28: 2706–2713.

CrossRef    PubMed

 

12.Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557–563.

CrossRef    PubMed

 

13.Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549–556.

 

14.Belliard G, Catez E, Charron C, Caille V, Aegerter P, Dubourg O, et al. efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation 2007;75:252–259.

CrossRef    PubMed

 

15.Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al.; American Heart Association. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2;122(18 Suppl 3):S768–86.

 

16.Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O’Dea D, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005;19:33–39.

CrossRef    PubMed

 

17.American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. Circulation.1998; 97: 1325–1335.

 

18.Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, Tu JV, Alter DA. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 2003;41:1573–1582.

CrossRef    PubMed

 

19.Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986 Jul 12;2(8498):57–66.

 

20.Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group. Am J Cardiol.1985 Nov 22;56(14):30G–34G.

CrossRef

 

21.Pizarro G, Fernández-Friera L, Fuster V, Fernández- Jiménez R, García- Ruiz JM, García-Álvarez A, et al. Long-Term Benefit of Early Pre- Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction: Results From the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol. 2014 Jun 10;63(22):2356–62.

CrossRef    PubMed

 

22.Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al.; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001 Jan 24-31;285(4):430–6.

CrossRef

 

23.Stenestrand U, Wallentin L; Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001 Apr 4;285(13):1711–8.

CrossRef

 

24.ISIS-4(Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction”, The Lancet 1995;345 (8951):669–682.

CrossRef

 

25.GISSI-3 Group. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. The Lancet. 1994. 343(8906):1115–22.

 

26.Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS- 1) Collaborative Group. Chin Med J (Engl). 1997 Nov;110(11):834–8.

 

27.Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8;366(9493):1267–78.

CrossRef    PubMed

 

28.Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med.. 1992 Sep 3;327(10):678–84.

CrossRef    PubMed

 

29.Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, et al.; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med.. 2003 Nov 13;349(20):1893–906.

CrossRef    PubMed

 

30.Ovricenco E, Sinescu C, Dinescu S. Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction. J Med Life. 2008 Jul- Sep;1(3):323–33.

PubMed

 

31.Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295–1297.

CrossRef    PubMed

 

32.Steg P, Lopez-de-Sà E, Schiele F, Hamon M, Meinertz T, Goicolea J, et al.; VIVIFY (eValuation of the Intra Venous If inhibitor ivabradine after STsegment elevation mYocardial infarction) investigators. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study. Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):270-9.

CrossRef

 

33.Fasullo S, Cannizzaro S, Maringhini G, Ganci F, Giambanco F, Vitale G, et al. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. J Card Fail. 2009 Dec;15(10):856–63.

CrossRef    PubMed

 

34.Lawler PR, Filion KB, Eisenberg MJ. efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and metaanalysis of randomized controlled trials. Am Heart J 2011;162(4):571-584 e57–2.

CrossRef    PubMed

.

.

Tel No: +603-7931 7900
Fax No: +603-7932 1400

 

 

D-13A-06, Menara Suezcap 1, KL Gateway,
No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari,
59200 Kuala Lumpur, Malaysia.

www.aseancardiology.org

ASEAN HEART Journal is Supported by Unrestricted Grant From 

Committed to therapeutic advances in cardiovascular research